Live-Cell Membrane Fluctuation Imaging for Label-Free Binding Kinetics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying molecular interactions with membrane proteins on live cells are laborious, invasive, and prone to noise from cell micromotion, making accurate in-situ measurements challenging.
Innovation Solution
A label-free optical imaging method that tracks nanometer-scale membrane fluctuations to measure molecular binding kinetics on single live cells, using a mechanically stable optical imaging system with a 40× phase contrast objective and differential detection algorithm to isolate membrane displacement signals from environmental noise.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioactive or fluorescent labels are used to study molecular interactions, then detection sensitivity is improved, but the method becomes invasive and suitable only for end-point detection rather than real-time kinetics
Solution Approach 1:
The patent extracts and eliminates the harmful labeling step from the detection system. By using label-free optical detection methods, the invention removes the invasive radioactive or fluorescent labels that previously compromised cell viability and limited measurements to end-point detection only.
Solution Approach 2:
The patent replaces the chemical/biological labeling approach with a physical optical detection method. Instead of using radioactive or fluorescent labels that require chemical attachment to molecules, the invention uses label-free optical techniques to detect molecular interactions through changes in light properties, thereby avoiding invasiveness while maintaining detection capability.
2Ease of manufacture
If membrane proteins are extracted from cell membranes for binding measurement, then label-free detection technology can be used, but the protein extraction process becomes laborious and difficult due to low solubility and low expression levels
Solution Approach 1:
The patent extracts and eliminates the complex protein extraction step from the workflow. By developing a method that detects molecular interactions directly on intact cell membranes, the invention removes the laborious extraction process that previously required overcoming low solubility and low expression level challenges.
Solution Approach 2:
The patent segments the detection process to work directly with the native cellular environment rather than requiring complete protein extraction. By detecting interactions on the cell surface in situ, the method preserves the native state of membrane proteins and avoids the complex extraction and reconstitution steps.
3Reliability
If in-situ quantification of membrane protein binding kinetics is performed on live cells, then native structure and function are preserved, but cell micromotion introduces noise that complicates accurate measurement
Solution Approach 1:
The patent uses mechanical vibration or oscillation at specific frequencies to differentiate between cell micromotion and actual binding events. By applying controlled mechanical stimuli or analyzing vibrations at characteristic frequencies, the method can filter out background noise from cell movement while preserving the signal from molecular binding interactions.
Solution Approach 2:
The patent implements feedback mechanisms to continuously monitor and compensate for cell micromotion. By real-time detection of cell position changes and active compensation through reference measurements or adaptive filtering, the system maintains measurement precision despite the inherent motion of live cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise, real-time quantification of molecular binding kinetics with sub-nanometer precision, providing non-invasive assessment of cell mechanics and molecular interactions, suitable for drug evaluation and disease analysis at the single-cell level.
Implementation Method 1
a 40× phase contrast objective
Implementation Method 2
based on detecting and tracking membrane fluctuation amplitude changes cause by membrane displacement associated with the binding of the substance with the surface membrane proteins. The molecular binding kinetics can be detected with high precision in real time from an optical image
Data Source
AI summary
Disclosed herein is a system and method for quantitative detection and analysis of molecular binding kinetics of a substance with surface membrane proteins of a biological object, such as a live cell, based on detecting and tracking membrane fluctuation amplitude changes caused by membrane displacement associated with the binding of the substance with the surface membrane proteins. The molecular binding kinetics can be detected with high precision in real time from an optical image of the biological object with a differential detection method.